MIP Diagnostics Overview
- Founded
- 2015
- Status
- Private
- Employees
- 19
- Latest Deal Type
- Later Stage VC
- Latest Deal Amount
- $6.38M
- Investors
- 7
MIP Diagnostics General Information
Description
Developer of molecular imprinted polymers (MIPS) and nanoMIPs/plastic antibodies technology designed to circumvent the drawbacks of traditional MIP manufacturing methods. The company's polymers and antibodies typically contain a single binding site for their target and can be fused to solid substrates, such as sensor surfaces, thus providing hospitals with ideal reagents for a wide range of applications including point-of-care diagnostics and in field-based testing.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Primary Office
- The Exchange Building
- Colworth Park, Sharnbrook
- Bedford MK44 1LQ
- England, United Kingdom
+44 01234 000000
MIP Diagnostics Timeline
MIP Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 01-Jul-2020 | $6.38M | 00.00 | 0000 | Completed | Generating Revenue |
| 5. Early Stage VC (Series A) | 08-May-2018 | 00.000 | 00.00 | 00.000 | Completed | Generating Revenue |
| 4. Early Stage VC | 28-Jun-2017 | 00000 | 00.000 | 00.000 | Completed | Generating Revenue |
| 3. Early Stage VC | 21-Oct-2016 | 00000 | 00000 | 00.000 | Completed | Startup |
| 2. Early Stage VC | 22-Dec-2015 | $274K | $274K | 00.000 | Completed | Startup |
| 1. Grant | Completed | Startup |
MIP Diagnostics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| C Ordinary | 00,000 | 00.000000 | 0000.00 | 0000.00 | 00 | 0000.00 | 00.000 | |
| C Ordinary | 0,000 | 00.000000 | 0000.00 | 0000.00 | 00 | 0000.00 | 0.000 | |
| A Ordinary | 00,000 | 00.000000 | 0000.00 | 0000.00 | 00 | 0000.00 | 00.000 | |
| B Ordinary | 0,000 | 00.000000 | 0000.00 | 0000.00 | 00 | 0000.00 | 0.000 | |
| B Ordinary | 0,000 | 00.000000 | 0000.00 | 0000.00 | 00 | 0000.00 | 0.000 | |
| A Ordinary | 0,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 0.000 | |
| A Ordinary | 3,308 | $0.012513 | $68.82 | $68.82 | 1x | $68.82 | 5.58% | |
| A Ordinary | 3,000 | $0.012513 | $62.56 | $62.56 | 1x | $62.56 | 5.06% |
MIP Diagnostics Executive Team (6)
MIP Diagnostics Board Members (7)
| Name | Representing | Role | Since |
|---|---|---|---|
| James Syrotiuk | Self | Board Member | 000 0000 |
| Jim Reid | MIP Diagnostics | Chairman | 000 0000 |
| Mark Payton Ph.D | Self | Board Member | 000 0000 |
| Stephane Argivier | MIP Diagnostics | Chief Executive Officer and Board Member | 000 0000 |
| William Brooks | Self | Board Member | 000 0000 |
MIP Diagnostics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialMIP Diagnostics Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| BGF | Growth/Expansion | Minority | 000 0000 | 000000 0 | |
| Downing Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Andrew Fisher | Angel (individual) | Minority | 000 0000 | 000000 0 | |
| Calculus Capital | PE/Buyout | Minority | 000 0000 | 000000 0 | |
| David Evans | Angel (individual) | Minority | 000 0000 | 000000 0 |